Health Care Down On Cyclical Bias - Health Care Roundup

Features Dow Jones Newswires

Shares of health-care companies ticked down as traders rotate into more rate-sensitive areas. A federal jury in Chicago ordered drug maker AbbVie to pay more than $140 million in damages to a Tennessee man who suffered a heart attack following use of its testosterone-replacement therapy AndroGel. Bayer has stopped a late stage study for the use of blood-thinning drug Xarelto, saying it showed no improved efficacy compared with another treatment using aspirin.

Continue Reading Below

-Rob Curran, rob.curran@dowjones.com

(END) Dow Jones Newswires

October 06, 2017 16:31 ET (20:31 GMT)